Richard Kirk - Pro Dex CEO
| PDEX Stock | USD 42.33 5.30 11.13% |
CEO
Mr. Richard L. Van Kirk Jr. is President, Chief Executive Officer, Chief Operating Officer, Director of the Company. He joined the Company as Director of Manufacturing in 2006, and was subsequently promoted to Vice President of Operations in 2007. Prior to joining the Company, Mr. Van Kirk served as Manufacturing Manager and Manager of Product Development for the ChargeSource division of Comarco, Inc., a provider of power and charging functionality for popular electronic devices and wireless accessories, and as General Manager at Dynacast, a leader in precision die casting since 2015.
| Age | 63 |
| Tenure | 9 years |
| Professional Marks | MBA |
| Address | 2361 McGaw Avenue, Irvine, CA, United States, 92614 |
| Phone | 949 769 3200 |
| Web | https://www.pro-dex.com |
Pro Dex Management Efficiency
The company has return on total asset (ROA) of 0.1005 % which means that it generated a profit of $0.1005 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1678 %, meaning that it created $0.1678 on every $100 dollars invested by stockholders. Pro Dex's management efficiency ratios could be used to measure how well Pro Dex manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.04 in 2024. Return On Capital Employed is likely to rise to 0.19 in 2024. At this time, Pro Dex's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 16.7 M in 2024, whereas Intangible Assets are likely to drop slightly above 51.3 K in 2024.Similar Executives
| Found 8 records | CEO Age | ||
| Andrew Astor | Nephros | 67 | |
| Robert Banks | Nephros | 49 | |
| Daron Evans | Nephros | 50 | |
| Leonard Osser | Milestone Scientific | 77 | |
| Matthias Schupp | Straumann Holding AG | 59 | |
| Linda Tharby | Repro Med Systems | 56 | |
| Jan Haverhals | Milestone Scientific | 62 | |
| Richard Diiorio | InfuSystems Holdings | 49 | |
Management Performance
Pro Dex Management Team
Elected by the shareholders, the Pro Dex's board of directors comprises two types of representatives: Pro Dex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pro. The board's role is to monitor Pro Dex's management team and ensure that shareholders' interests are well served. Pro Dex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pro Dex's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Chris Jackson, Directors Operations | ||
| Richard Kirk, CEO and President COO, Director and Member of Investment Committee | ||
| Alisha Charlton, CFO Secretary |
Pro Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pro Dex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.1 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 161.97 M | ||||
| Shares Outstanding | 3.26 M | ||||
| Shares Owned By Insiders | 35.92 % | ||||
| Shares Owned By Institutions | 27.72 % | ||||
| Number Of Shares Shorted | 18.98 K | ||||
| Price To Earning | 13.30 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pro Stock Analysis
When running Pro Dex's price analysis, check to measure Pro Dex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Dex is operating at the current time. Most of Pro Dex's value examination focuses on studying past and present price action to predict the probability of Pro Dex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Dex's price. Additionally, you may evaluate how the addition of Pro Dex to your portfolios can decrease your overall portfolio volatility.